Maria Celles, NP
Nurse Practitioner · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
Offices
3 locations
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Maria Celles’s office to ask if they take your plan before you enroll.
Original Medicare doctor bills
$5,289
Medicare paid this office $5,289 for 18 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
18 Original Medicare patients in 2024. Average age 53 · Also on Medicaid 100% · Health risk score 1.23. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
The office billed $34,350, Medicare allowed $7,533 and paid $5,289; for 51 services of 7 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 18 | 51 | 53 | 1.23 | $34,350 | $5,289 |
| 2023 | 16 | 52 | 52 | 0.84 | $43,230 | $4,231 |
| 2022 | 29 | 117 | 59 | 1.32 | $93,625 | $11,036 |
| 2020 | 17 | 63 | 68 | 0.76 | $17,608 | $4,599 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2022: 4 services
| Long return visit (40+ min) | 13 | $3,026 | $132 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $2,334 | $101 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $1,471 | $70 |
| Psychiatric diagnostic evaluation with medical services | 11 | $1,355 | $113 |
2020: 2 services
| Return visit (30+ min) | 11 | $2,249 | $87 |
| Psychiatric diagnostic evaluation with medical services | 12 | $900 | $75 |
Medicaid work
$18,414 in 2022
Medicaid paid $18,414 for 150 billed services this clinician did in 2022, up to 34 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 74 | $17,378 |
| Return visit (30+ min) | 76 | $1,036 |
| 2022 | 150 | 2 | 34 | $18,414 |
| 2021 | 2,023 | 6 | 58 | $194,464 |
| 2020 | 228 | 3 | 31 | $28,796 |
See the largest Medicaid services in earlier years
2021
| Clinic visit/encounter, all-inclusive | 950 | $190,937 |
| Return visit (30+ min) | 637 | $1,880 |
| Long return visit (40+ min) | 140 | $743 |
| Short return visit (20+ min) | 248 | $713 |
| Psychiatric diagnostic evaluation with medical services | 31 | $190 |
| Short return visit | 17 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 137 | $28,796 |
| Psychiatric diagnostic evaluation with medical services | 35 | $0 |
| Return visit (30+ min) | 56 | $0 |
Drugs they prescribed that Part D paid
$149,841
Pharmacies billed $149,841 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 431) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
406 generic and 25 brand-name prescriptions · $149,841 in drug cost · 37 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Lurasidone | 25 | $7,460 | $298 |
| Aripiprazole | 41 | $1,081 | $26 |
| Clozapine | 17 | $830 | $49 |
| Quetiapine | 33 | $535 | $16 |
| Bupropion Xl | 25 | $213 | $9 |
See all 12 drugs
| Lurasidone | 25 | $7,460 | $298 |
| Aripiprazole | 41 | $1,081 | $26 |
| Clozapine | 17 | $830 | $49 |
| Quetiapine | 33 | $535 | $16 |
| Bupropion Xl | 25 | $213 | $9 |
| Hydroxyzine | 22 | $191 | $9 |
| Sertraline | 29 | $185 | $6 |
| Prazosin | 15 | $155 | $10 |
| Propranolol | 22 | $142 | $6 |
| Escitalopram | 41 | $95 | $2 |
| Venlafaxine Hcl Er | 17 | $77 | $5 |
| Mirtazapine | 15 | $67 | $4 |
Year by year
| 2024 | 431 | 25 | 0% (0) | 6% | $149,841 |
| 2023 | 413 | 23 | 0% (0) | None | $27,469 |
| 2022 | 528 | 42 | 0% (0) | 7% | $97,481 |
| 2021 | 126 | 19 | 0% (0) | 16% | $37,662 |
| 2020 | 176 | 53 | 0% (0) | 6% | $9,238 |
| 2019 | 14 | 12 | 0% (0) | None | $686 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 16 drugs
| Lurasidone | 17 | $9,078 | $534 |
| Olanzapine | 26 | $1,122 | $43 |
| Quetiapine | 23 | $1,106 | $48 |
| Aripiprazole | 16 | $1,093 | $68 |
| Trazodone | 35 | $646 | $18 |
| Escitalopram | 31 | $471 | $15 |
| Bupropion Xl | 13 | $412 | $32 |
| Buspirone | 26 | $362 | $14 |
| Lithium Carbonate | 21 | $256 | $12 |
| Sertraline | 32 | $226 | $7 |
| Hydroxyzine | 15 | $209 | $14 |
| Mirtazapine | 15 | $204 | $14 |
| Risperidone | 13 | $172 | $13 |
| Fluoxetine | 13 | $171 | $13 |
| Propranolol | 17 | $144 | $8 |
| Lamotrigine | 18 | $144 | $8 |
2022: 18 drugs
| Latuda | 16 | $36,645 | $2,290 |
| Abilify Maintena | 12 | $30,020 | $2,502 |
| Quetiapine | 37 | $4,443 | $120 |
| Haloperidol Decanoate | 15 | $1,184 | $79 |
| Olanzapine | 24 | $928 | $39 |
| Clozapine | 20 | $899 | $45 |
| Aripiprazole | 14 | $641 | $46 |
| Bupropion Xl | 25 | $519 | $21 |
| Mirtazapine | 35 | $422 | $12 |
| Escitalopram | 29 | $367 | $13 |
| Trazodone | 34 | $349 | $10 |
| Risperidone | 35 | $342 | $10 |
| Lorazepam | 18 | $257 | $14 |
| Benztropine Mesylate | 15 | $243 | $16 |
| Clonazepam | 13 | $237 | $18 |
| Sertraline | 37 | $175 | $5 |
| Lithium Carbonate | 25 | $172 | $7 |
| Lamotrigine | 13 | $105 | $8 |
2021: 3 drugs
| Duloxetine | 15 | $1,413 | $94 |
| Quetiapine | 19 | $743 | $39 |
| Aripiprazole | 12 | $386 | $32 |
2020: 2 drugs
| Lamotrigine | 21 | $154 | $7 |
| Lorazepam | 14 | $60 | $4 |
Professional record
- NPI
- 1912377573
- Licence
- CA NP95012949
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LP0808X (363LP0808X); Federal specialty code 101YM0800X (101YM0800X)
- Mailing address
- 3061 Fillmore St, San Francisco, CA, 94123
- NPI first listed
- 2015-09-25
- NPI last updated
- 2026-07-09
- NPI record certified
- 2026-07-09
This is when the NPI record was last certified, not a medical board exam.